2-Epi-fortimicin A and derivatives

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424181, 536 161, A61K 3171, C07H 1522

Patent

active

043318045

ABSTRACT:
What is described is 2-epi-fortimicin A, 2-epi-fortimicin B or a 2-epi-fortimicin B derivative represented by the formula: ##STR1## wherein R.sub.1 is hydrogen or loweralkyl; R.sub.2 is hydrogen or hydroxy; R.sub.3 is methyl or hydrogen; and R.sub.4 is selected from the group consisting of hydrogen, loweralkyl, aminoloweralkyl, diaminoloweralkyl, N-loweralkylaminoalkyl, N,N-diloweralkylaminoloweralkyl, hydroxyloweralkyl, aminohydroxyloweralkyl, N-loweralkylaminohydroxyloweralkyl, N,N-diloweralkylaminohydroxyloweralkyl, acyl of the formula ##STR2## wherein R.sub.5 is loweralkyl, aminoacyl, diaminoacyl, hydroxyacyl, N-loweralkylaminoacyl, N,N-diloweralkylaminoacyl, hydroxy-substituted aminoacyl or an amino acid residue other than those defined above and the pharmaceutically acceptable salts thereof useful in the treatment of infections.

REFERENCES:
patent: 4091032 (1978-05-01), Tadanier et al.
patent: 4169198 (1979-09-01), Martin et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-Epi-fortimicin A and derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-Epi-fortimicin A and derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Epi-fortimicin A and derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2077734

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.